EZER Hargabka & COVID-19 Antigen Combo Tijaabo Degdeg ah
Hordhac
Fayraska hargabka waxaa iska leh qoyskaOrthomyxoviridae, iyo difaac ahaan kala duwan, fayraska RNA-ka-xidhan.Halkaa waxaa jira fayraska hargabka A iyo B waa cudur-sidaha ugu weyn ee cudurrada daran ku dhaca dadka iyo noocyada xoolaha.Iyada oo ku saleysan baaritaanka cudurrada faafa ee hadda, muddada soo-baxa waa 1 ilaa 4 maalmood.Calaamadaha ugu waaweyn waxaa ka mid ah qandho ba'an, xanuun guud iyo calaamadaha neefsashada.Labada nooc ee A iyo fayrasyada B isku mar bay wareegi karaan, laakiin inta badan hal nooc ayaa ku badan inta lagu jiro xilli go'an.
COVID-19 waa cudur faafa oo neef-mareenka oo degdeg ah.Dadku guud ahaan waa u nugul yihiin.Hadda, bukaannada uu ku dhacay cudurka 'coronavirus' cusub ayaa ah isha ugu weyn ee caabuqa;Dadka cudurka asymptomatic-ka ah sidoo kale waxay noqon karaan il faafa.Iyada oo ku saleysan baaritaanka cudurrada faafa ee hadda, muddada soo-baxa waa 1 ilaa 14 maalmood, badiyaa 3 ilaa 7 maalmood.Calaamadaha ugu waaweyn waxaa ka mid ah qandho, daal iyo qufac qalalan.Sanka oo ciriiri ah, diif, cune xanuun, myalgia iyo shuban ayaa laga helaa dhowr xaaladood.
Calaamadaha bukaan-socodka iyo calaamadaha caabuqa fayraska neef-mareenka ee uu keeno SARS-CoV-2 iyo hargabku waxay la mid noqon karaan.SARS-CoV-2, hargabka A iyo hargabka B fayras antigens ayaa guud ahaan laga ogaan karaa shaybaarada neef-mareenka sare inta lagu jiro marxaladda ba'an ee caabuqa.
EZERTMHargabka & COVID-19 Antigen Combo Tijaabada degdega ah waxaa ka mid ah baaritaanka degdega ah ee hargabka antigen iyo COVID-19 antigen-ka degdega ah, waa imtixaan immunochromatographic ah oo lagu ogaanayo tayada 2019 Novel Coronavirus, hargabka A iyo B antigens.EZERTMHargabka & COVID-19 Antigen Combo Rapid Test waxa uu leeyahay afar xaraf oo korka xariijinta ee tilmaamaya xariiqda tijaabada (S)﹑ (A)﹑ (B) iyo xariiqa xakamaynta (C).
Ogaanshaha
EZERTMFlu&COVID-19 Antigen Combo Tijaabada Degdega ah waxaa loogu talagalay in isku mar la ogaado tayada tayada iyo kala soocida antigens-ka borotiinka nucleocapsid ee SARS-CoV-2, hargabka A iyo hargabka B ee muunadaha sanka ee tooska ah.
Tusaalooyinka
Sanka
Xadka ogaanshaha (LoD)
Hargabka & COVID-19: 140 TCID50/ml
Xadka ogaanshaha ugu yar ee Hargabka A ee EZERTMFlu&COVID-19 Antigen Combo Tijaabooyin Degdeg ah ayaa la sameeyay iyadoo lagu salaynayo wadarta 8 hargabka A.
Cadaadiska Fayraska Hargabka | LoD la xisaabiyay |
A/New Caledonia/20/1999_H1N1 | 8.50x103 |
A/California/04/2009_H1N1 | 2.11x103 |
A/PR/8/34_H1N1 | 2.93x103 |
A/Bean Goose/Hubei/chenhu XVI35-1/2016_H3N2 | 4.94x102 |
A/Guizhou/54/89_H3N2 | 3.95x102 |
A/ Aadanaha/Hubei/3/2005_H3N2 | 2.93x104 |
Goose-madaxeed leh ee Bar/QH/BTY2/2015_H5N1 | 1.98x105 |
A/Anhui/1/2013_H7N9 | 7.90x105 |
Xadka ogaanshaha ugu yar ee hargabka B ee EZERTMFlu&COVID-19 Antigen Combo Tijaabo Degdeg ah ayaa la sameeyay iyadoo lagu salaynayo wadarta 2 hargabka B.
Cadaadiska Fayraska Hargabka | LoD la xisaabiyay |
B/Victoria | 4.25x103 |
B/Yamagata | 1.58x102 |
Saxnaanta
| Hargabka A | Hargabka B | COVID-19 |
Dareenka Qaraabada | 86.8% | 91.7% | 96.6% |
Gaar ahaan Qaraabada | 94.0% | 97.5% | 100% |
Saxnaanta | 92.2% | 96.1% | 98.9% |
Waqtiga natiijada
Natiijooyinka ku akhri 15daqiiqo oo aan ka badnayn 30 daqiiqo.
Xaaladaha kaydinta qalabka
2 ~ 30°C
Nuxurka
Sharaxaada | Qty |
Qalabka tijaabi | 20 |
suufyo jeermis dilay | 20 |
Tuubooyinka soo saarista | 20 |
Nozzles | 20 |
Tube istaag | 1 |
Gelida xirmada | 1 |
Dalbashada Macluumaadka
Alaabta | Bisad.Maya. | Nuxurka |
EZERTMHargabka & COVID-19 Antigen Combo | P213110 | 20 imtixaan |